CTN 328: immunogenicity outcomes in people living with HIV in Canada following vaccination for COVID-19 (HIV-COV): protocol for an observational cohort study

INTRODUCTION: Most existing vaccines require higher or additional doses or adjuvants to provide similar protection for people living with HIV (PLWH) compared with HIV-uninfected individuals. Additional research is necessary to inform COVID-19 vaccine use in PLWH. METHODS AND ANALYSIS: This multicent...

Descripción completa

Detalles Bibliográficos
Autores principales: Costiniuk, Cecilia T, Singer, Joel, Langlois, Marc-André, Kulic, Iva, Needham, Judy, Burchell, Ann, Jenabian, Mohammad-Ali, Walmsley, Sharon, Ostrowski, Mario, Kovacs, Colin, Tan, Darrell, Harris, Marianne, Hull, Mark, Brumme, Zabrina, Brockman, Mark, Margolese, Shari, Mandarino, Enrico, Angel, Jonathan B, Routy, Jean-Pierre, Anis, Aslam H, Cooper, Curtis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
HIV/AIDS
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8678543/
https://www.ncbi.nlm.nih.gov/pubmed/34916326
http://dx.doi.org/10.1136/bmjopen-2021-054208

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8678543/
https://www.ncbi.nlm.nih.gov/pubmed/34916326
http://dx.doi.org/10.1136/bmjopen-2021-054208

Ejemplares similares